By Gabe Kaminsky (Washington Examiner)
Sen. Jacky Rosen (D-NV), who faces a tough 2024 reelection bid in the swing state of Nevada, reaped a windfall in profits from her investments in companies that have jacked up drug prices — all while the Democrat has touted support for lowering them.
Rosen has described on social media how she hears from “constituents every week who are concerned about the rising cost of prescription drugs” and has vowed to “keep fighting to lower prescription drug costs for everyone.” The Nevada Democrat, whom Republicans have slammed over her campaign spending cash at luxury restaurants and hotels, disclosed in 2022 holding up to roughly $300,000 in shares of major pharmaceutical and biotechnology companies.